| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.0055 | 1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.0042 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.00066 | 1 |